«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:

2023年03期

页码:

170-174

栏目:

临床研究

出版日期:

2023-05-30

文章信息/Info

Title:

Identification and functional assay of a new MESP2 mutation responsible for congenital patent ductus arteriosus?

作者:

严梓; 陈春英; 杨奕清; 刘兴元

200065 上海，同济大学医学院附属同济医院儿科（严梓，陈春英，刘兴元）,200240 复旦大学附属上海市第五人民医院心内科、心血管研究室、中心实验室（杨奕清）

Author(s):

YAN Zi; CHEN Chunying; YANG Yiqing; LIU Xingyuan1.

Department of Pediatrics, Tongji University School of Medicine, Shanghai? 200065

关键词:

先天性动脉导管未闭; 分子遗传学; 转录因子; MESP2基因; 报告基因分析

Keywords:

Congenital patent ductus arteriosus;  Molecular genetics;  Transcriptional factor;  MESP2;  Reporter gene assay

分类号:

-

DOI:

10.3969/j.issn.1673-6583.2023.03.011

文献标识码:

-

摘要:

目的：研究先天性动脉导管未闭（PDA）致病基因MESP2新突变。方法：选取2016年2月至2019年11月同济大学医学院附属同济医院儿科208例先天性心脏病（CHD）患儿和232名无CHD儿童，收集其血液标本及临床数据。常规纯化基因组DNA，测序分析转录因子基因MESP2以发现新的致病突变。克隆野生型MESP2基因并构建其真核表达质粒，通过定位诱变产生突变型MESP2表达质粒，转染HEK293T细胞，通过报告基因分析揭示突变体的功能特性。结果：1例散发性先天性动脉导管未闭（PDA）患者检测出1个MESP2基因新突变，即NM_001039958.2:c.268G＞T（p.Glu90*）突变。该突变不存在于对照组和其他CHD儿童中。报告基因分析显示突变型MESP2对靶基因NKX2.5的转录激活功能丧失。结论：MESP2基因缺陷可能是部分先天性PDA的分子病因，为先天性PDA的防治提供了新的分子靶标。

Abstract:

Objective: To investigate a new MESP2 mutation underpinning congenital patent ductus arteriosus (PDA).? Methods: A cohort of 208 children inflicted with congenital heart disease (CHD) and a total of 232 control subjects with no CHD were recruited, and their blood specimens and clinical data were collected. Genomic DNA was routinely isolated from each study participant's blood leucocytes, which was utilized for sequencing analysis of the MESP2 gene to identify a new mutation contributing to CHD. The wild-type MESP2 gene was cloned, with its eucaryotic expression plasmid constructed. The mutant-type MESP2 expression plasmid was produced through site-directed mutagenesis. HEK 293T cells were transfected with various expression plasmids, and the functional characteristics of the mutant-type MESP2 were revealed by reporter gene analysis.? Results: In a child suffering from sporadic congenital PDA, a new MESP2 mutation, NM_001039958.2: c.268G＞T (p.Glu90*), was detected, which was not observed in the control group or other CHD children. Reporter gene analysis showed that the mutant MESP2 failed to transcriptionally activate its target gene NKX2.5.? Conclusion: MESP2 defect is likely to be a molecular etiology giving rise to congenital PDA in a subset of patients, providing a novel molecular target for the medical prophylaxis and therapy of congenital PDA.

参考文献/References

[1]Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics—2008 update:a report from the American Heart Association[J]. Circulation, 2018, 137(12):e67-e492.[2]Huang RT, Guo YH, Yang CX, et al. SOX7 loss-of-function variation as a cause of familial congenital heart disease[J]. Am J Transl Res, 2022, 14(3):1672-1684.
[3]Lahm H, Deutsch MA, Dre?en M, et al. Mutational analysis of the human MESP1 gene in patients with congenital heart disease reveals a highly variable sequence in exon 1[J]. Eur J Med Genet, 2013, 56(11):591-598.
[4]Werner P, Latney B, Deardorff MA, et al. MESP1 mutations in patients with congenital heart defects[J]. Hum Mutat, 2016, 37(3):308-314.
[5]Zhang M, Li FX, Liu XY, et al. MESP1 loss-of-function mutation contributes to double outlet right ventricle[J]. Mol Med Rep, 2017, 16(3):2747-2754.
[6]Diab NS, Barish S, Dong WL, et al. Molecular genetics and complex inheritance of congenital heart disease[J]. Genes (Basel), 2021, 12(7):1020.
[7]Saga Y. Genetic rescue of segmentation defect in MesP2-deficient mice by MesP1 gene replacement[J]. Mech Dev, 1998, 75(1/2):53-66.
[8]Kitajima S, Takagi A, Inoue T, et al. MesP1 and MesP2 are essential for the development of cardiac mesoderm[J]. Development, 2000, 127(15):3215-3226.
[9] 乔祺，杨晨曦，顾佳宁，等．KLF15基因突变导致心房颤动的机制[J]．国际心血管病杂志，2021，48(1)：53-57.
[10] Zhang E, Yang J, Liu Y, et al. MESP2 variants contribute to conotruncal heart defects by inhibiting cardiac neural crest cell proliferation[J]. J Mol Med (Berl), 2020, 98(7):1035-1048.
[11] Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5[J]. Science, 1998, 281(5373):108-111.
[12] Peng T, Wang L, Zhou SF, et al. Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease[J]. Genetica, 2010, 138(11):1231-1240.
[13] Reamon-Buettner SM, Borlak J. NKX2-5: an update on this hypermutable homeodomain protein and its role in human congenital heart disease (CHD) [J]. Hum Mutat, 2010, 31(11):1185-1194.
[14] Garg V, Kathiriya IS, Barnes R, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5[J]. Nature, 2003, 424(6947):443-447.
[15] Yu Y, Lei W, Yang JJ, et al. Functional mutant GATA4 identification and potential application in preimplantation diagnosis of congenital heart diseases[J]. Gene, 2018, 641:349-354.
[16] Ajima R, Sakakibara Y, Sakurai-Yamatani N, et al. Formal proof of the requirement of MESP1 and MESP2 in mesoderm specification and their transcriptional control via specific enhancers in mice[J]. Development, 2021, 148(20):dev194613.
[17] Saga Y, Miyagawa-Tomita S, Takagi A, et al. MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube[J]. Development, 1999, 126(15):3437-3447.

备注/Memo

备注/Memo:

基金项目：上海市自然科学基金（16ZR1432500）

常用功能

更新日期/Last Update: 2023-05-30